Certificate under Regulation 74(5) of SEBI (Depositories And Participants) Regulations, 2018 for the quarter ended 30th June, 2025
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals has submitted a quarterly compliance certificate under SEBI's Regulation 74(5) for the quarter ended 30 June 2025. The certificate was issued by MUFG Intime India (formerly Link Intime), the company's Registrar and Share Transfer Agent. It confirms that all share certificates received for dematerialisation during the quarter were properly verified, accepted or rejected by the depositories, and that the physical certificates were mutilated and cancelled. The depositories' names have been substituted as registered owners in the company's member records within the SEBI-prescribed timelines.
This is a routine procedural compliance filing required every quarter and has no material impact on the company's business, financials, or stock price.